Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial

Journal:

The Lancet

Published:

2026-03-29

DOI:

10.1016/s0140-6736(26)00308-9

Affiliations:

14

Authors:

20

Go to article

Institutions	Authors	Share
Amsterdam UMC, Netherlands	6.500000	0.33
Radboud University Medical Centre (Radboudumc), RU, Netherlands	2.000000	0.10
University Medical Center Utrecht (UMC Utrecht), Netherlands	1.500000	0.08
St. Antonius Hospital, Netherlands	1.500000	0.08
HAGA Hospital, Netherlands	1.000000	0.05
Amphia Hospital, Netherlands	1.000000	0.05
Medical Spectrum Twente, Netherlands	1.000000	0.05
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.05
Onze Lieve Vrouwen Gasthuis (OLVG), Netherlands	1.000000	0.05
Frisius MC, Netherlands	1.000000	0.05
Maastricht University Medical Center+ (Maastricht UMC+), Netherlands	1.000000	0.05
Maastricht University (UM), Netherlands	0.500000	0.03
Catharina Hospital, Netherlands	0.500000	0.03
Eindhoven University of Technology (TU/e), Netherlands	0.500000	0.03

Interested in Cardiovascular Medicine and Haematology?